Skip to content
HowShorted

Allogene Therapeutics, Inc. short interest in 2019

In 2019, Allogene Therapeutics, Inc.'s disclosed short interest ran from 10.32% of shares outstanding on 15 Oct 2019 to 10.52% on 31 Dec 2019, a change of +0.20 percentage points. The year's high was 10.52% on 31 Dec 2019 and its low 9.60% on 13 Dec 2019, averaging 10.04% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 44.87 days on 31 Oct 2019. Full history: Allogene Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Allogene Therapeutics, Inc. in 2019

2019 in figures

Start of year
10.32% (15 Oct 2019)
End of year
10.52% (31 Dec 2019)
Change
+0.20 pp
High
10.52% (31 Dec 2019)
Low
9.60% (13 Dec 2019)
Average
10.04%
Highest days to cover
44.87 (31 Oct 2019)
SEC filings marked
8

Every report in 2019

Allogene Therapeutics, Inc. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Oct 201910.32%37.9710-K filed, results (8-K), 10-Q filed, results (8-K), 10-Q filed, results (8-K)
31 Oct 201910.20%44.87
15 Nov 20199.98%33.7210-Q filed, results (8-K)
29 Nov 20199.65%23.06
13 Dec 20199.60%14.90
31 Dec 201910.52%15.18

See also: Allogene Therapeutics, Inc.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.